U.S. Energy Services Stock News

NYSE:CBT
NYSE:CBTChemicals

Is Cabot (CBT) Quietly Shifting Its Core Story From Reinforcement Materials To Battery Materials?

Cabot recently reported its first-quarter fiscal 2026 results, beating earnings estimates despite year-over-year declines in sales and volumes and trimming its full-year adjusted EPS outlook amid softer demand in Reinforcement Materials. At the same time, Cabot highlighted growing earnings contributions from its Performance Chemicals segment, particularly Battery Materials, where a stronger product mix and cost controls are offsetting weakness elsewhere in the portfolio. We’ll now explore...
NYSE:TDS
NYSE:TDSWireless Telecom

What Telephone and Data Systems (TDS)'s Wireless Exit and Fiber Pivot Means For Shareholders

Telephone and Data Systems recently attracted contrasting institutional interest, with VR Advisory Services initiating a new US$23.49 million position while Quantbot Technologies cut its holdings by more than half following the company’s sale of its UScellular wireless operations and related rebranding to Array Digital. This mix of increasing commitment from one fund and reduced exposure from another highlights how investors are reassessing TDS’s shift toward a fiber- and tower-focused...
NasdaqGS:GO
NasdaqGS:GOConsumer Retailing

Grocery Outlet Holding (GO) Is Down 28.8% After Impairment-Driven Losses And Store Closures - Has The Bull Case Changed?

Grocery Outlet Holding Corp. recently reported past fourth-quarter 2025 results showing sales of US$1,215.27 million but a net loss of US$218.16 million, driven largely by US$110.17 million of long-lived asset impairments and US$149.00 million of goodwill impairments, alongside plans to close 36 underperforming stores while still opening 30–33 new locations in 2026. At the same time, the company issued cautious 2026 guidance calling for net sales of US$4.60 billion to US$4.72 billion with...
NYSE:RGA
NYSE:RGAInsurance

Reinsurance Group Of America Investment Shift With Bronchetti And Valuation Gap

Reinsurance Group of America (NYSE:RGA) has appointed Jayson Bronchetti as Executive Vice President, Investments. Bronchetti will succeed Leslie Barbi, who is retiring from the role. The appointment places Bronchetti in charge of the insurer's investment management function. Reinsurance Group of America, trading at $207.17, has experienced varying share price movements across different timeframes, with a 7 day return of a 4.5% decline and a 30 day return of an 8.1% decline, alongside a 1...
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

Will Victory Capital’s New CTO and AI Lead Reshape VCTR’s Technology-Driven Investment Narrative?

In March 2026, Victory Capital Holdings, Inc. appointed Molly Weiss as Chief Technology Officer and Head of Digital Innovation, giving her executive responsibility for the firm’s technology infrastructure, artificial intelligence framework, data and analytics platform, and Direct Investor Business. By placing a seasoned wealth-technology leader with product, distribution, and user-experience expertise at the center of its technology and direct-investor efforts, Victory Capital appears to be...
NYSE:TPH
NYSE:TPHConsumer Durables

Did Soft 2025 Results and Utah Expansion Just Shift Tri Pointe Homes' (TPH) Investment Narrative?

Tri Pointe Homes, Inc. recently reported fourth-quarter 2025 revenue of US$954.59 million and net income of US$60.16 million, with full-year revenue of US$3.40 billion and net income of US$241.09 million, all lower than the prior year. A day later, the company highlighted product expansion by unveiling Aspire at Holladay Hills in Utah, its first townhome community in the state, featuring 57 units with interiors designed by Emmy-winning Bobby Berk. We’ll now examine how the weaker 2025...
NasdaqGS:LQDT
NasdaqGS:LQDTCommercial Services

Will Analyst Upgrades And Earnings Revisions Recast Liquidity Services' (LQDT) E-Commerce Surplus Niche?

Recently, Liquidity Services was highlighted by Zacks as one of four services-sector stocks benefiting from favorable earnings estimate revisions and a strong buy rating, underscoring its role as an e-commerce marketplace for surplus assets. This recognition reflects growing analyst confidence in the company’s business model and earnings profile, rather than any single operational announcement. Next, we’ll consider how this uptick in analyst optimism and earnings estimate revisions could...
NYSE:NMM
NYSE:NMMShipping

Is Navios Maritime Partners (NMM) Quietly Recasting Its Strategy Around Geopolitical Trade Disruptions?

Navios Maritime Partners L.P. recently presented at the DNB Carnegie Energy & Shipping Conference in Oslo, where its CFO and COO outlined current industry conditions and company positioning. Alongside this, CEO Angeliki Frangou has argued that rising geopolitical tensions, especially around Iran and the Strait of Hormuz, are reshaping global trade patterns and driving higher crude shipping rates under an emerging mercantilist, security-first world order. We will now examine how management’s...
NYSE:SGI
NYSE:SGIConsumer Durables

Assessing Somnigroup International (SGI) Valuation After Recent Share Price Weakness

Why Somnigroup International (SGI) is on investors’ radar Somnigroup International (SGI) recently rebranded from Tempur Sealy International, a change that draws attention to how this bedding manufacturer’s shares have behaved after a 3% one day and 8% week decline. See our latest analysis for Somnigroup International. The recent 1 day share price return of 3.05% and 7 day return of 8.49% sit against a 30 day share price decline of 16.94% and a year to date decline of 9.85%, while the 1 year...
NYSE:CMS
NYSE:CMSIntegrated Utilities

CMS Energy Links Earnings Upgrade To 20 Year Renewable Growth Plan

CMS Energy (NYSE:CMS) reported strong Q4 2025 results and raised its 2026 EPS guidance. The company introduced a 20-year plan centered on expanding solar and wind capacity. Management highlighted the long-term shift towards renewable energy alongside financial updates. For investors watching NYSE:CMS, these updates come with the stock at $77.16 and a return of 53.7% over the past 5 years. The recent 9.6% gain year to date and 42.6% return over 3 years show how the share price has moved over...
NYSE:RPM
NYSE:RPMChemicals

RPM International Deal For Kalzip Raises Questions On Undervaluation

Tremco, a unit of RPM International (NYSE:RPM), has agreed to acquire Kalzip GmbH. The deal brings Kalzip’s aluminum building envelope systems into RPM’s building solutions portfolio. The acquisition is expected to expand RPM’s reach across Europe, India, and North America. RPM International, through its Tremco segment, focuses on building envelope products such as roofing, waterproofing, and related systems. Adding Kalzip’s metal roofing and façade solutions fits within that core line of...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA) Valuation Check As GAAP Profitability And GLP 1 Flex Care Launch Draw Fresh Attention

Omada Health (OMDA) is back in focus after reporting its first GAAP profitable quarter, alongside revenue growth in 2025 and improved margins, while also rolling out its GLP-1 Flex Care program for employers. See our latest analysis for Omada Health. The recent earnings beat, first GAAP profitable quarter and launch of GLP-1 Flex Care have coincided with a 20.6% 1 month share price return. However, the negative 90 day and year to date share price returns suggest momentum has only recently...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Is Corvus Pharmaceuticals (CRVS) Now Attractive After Recent Share Price Volatility?

If you are wondering whether Corvus Pharmaceuticals' recent share price puts it at a bargain or a stretched level, you are not alone. This article is here to unpack what that current price might mean for value focused investors. The stock has been volatile, with a 7 day return of an 11.7% decline and a 30 day return of a 22.8% decline, set against a year to date return of 115.8% and a 1 year return of 271.6%, plus an increase of more than 7x over 3 years and 381.6% over 5 years. Recent...
NYSE:ESS
NYSE:ESSResidential REITs

How Earnings Miss and Modest Dividend Hike Will Impact Essex Property Trust (ESS) Investors

In recent days, Essex Property Trust’s fourth-quarter 2025 results came in below expectations while the company’s board approved a 0.8% annual dividend increase, marking its 32nd consecutive year of dividend growth. At the same time, a mix of cautious analyst commentary and industry concerns about below pre-COVID multifamily occupancy levels has sharpened investor focus on how Essex balances income stability with near-term operational challenges. Next, we’ll examine how Essex’s earnings...
NYSE:CIVI
NYSE:CIVIOil and Gas

Assessing Civitas Resources (CIVI) Valuation After Weaker Full Year 2025 Results

Full year 2025 earnings reset the conversation Civitas Resources (CIVI) recently reported full year 2025 results, with revenue of US$4,393 million and net income of US$561 million, both lower than the prior year, putting the stock back under closer investor review. See our latest analysis for Civitas Resources. At a share price of US$27.38, Civitas Resources has seen a 5.0% decline in its 90 day share price return and a 43.4% drop in its 1 year total shareholder return. This suggests momentum...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Why Flywire (FLYW) Is Up 6.8% After AI-Focused CTO Hire And 2026 Guidance Update - And What's Next

In late February 2026, Flywire reported fourth-quarter 2025 sales of US$157.54 million and net income of US$0.033 million, alongside full-year 2025 sales of US$623.03 million and net income of US$13.5 million, issued 2026 growth guidance, filed a US$77.86 million ESOP-related shelf registration, and reshaped its technology leadership. The appointment of seasoned payments technologist Patrick Blanc as Chief Technology Officer, coupled with Flywire’s AI-first engineering push and Student...
NYSE:IOT
NYSE:IOTSoftware

US Stock Market Today: S&P 500 Futures Fall On Higher Yields And Oil Surge

The Morning Bull - US Market Morning Update Monday, Mar, 9 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 1.3% and Nasdaq 100 futures off roughly 1.5%, as investors react to a jump in borrowing costs and energy prices. The US 10 year Treasury yield is around 4.22%, meaning mortgages, car loans, and corporate borrowing can all stay more expensive for longer, while oil above US$100 keeps pressure on fuel and transport costs. With Middle East...
OTCPK:AIMN
OTCPK:AIMNAuto

Assessing RONN Stock’s Valuation After A 99% Short Term Surge And A 50% One Year Decline

Why RONN Stock Is On Traders’ Radar RONN (RONN) has drawn attention after sharp recent swings, with returns around 99% over the past week and past 3 months, putting this small zero emission vehicle developer back in focus for speculative investors. See our latest analysis for RONN. That surge in recent share price returns over the past week and past quarter comes after a much tougher stretch, with the 1 year total shareholder return still showing a 50% decline. This highlights how quickly...
NYSE:RYAN
NYSE:RYANInsurance

A Look At Ryan Specialty Holdings (RYAN) Valuation After Revenue Growth Acquisitions And The Empower Program

Ryan Specialty Holdings (RYAN) is back in focus after reporting 2025 revenue of more than US$3.05b, completing five acquisitions, and launching its three year Empower Program to streamline operations and cut costs. See our latest analysis for Ryan Specialty Holdings. Despite the Empower Program and recent acquisitions getting attention, Ryan Specialty Holdings’ 1 day share price return of 1% and 7 day share price return of 0.9% sit against a 30 day share price decline of 16.4%, a year to date...
NasdaqGS:BELF.A
NasdaqGS:BELF.AElectronic

Is It Time To Reassess Bel Fuse (BELF.A) After The Recent Share Price Pullback

If you are wondering whether Bel Fuse shares still offer value after a strong run, this article explains what the current price might be implying about the business. The stock closed at US$172.94 recently, with a 7 day return of an 18.4% decline and a 30 day return of a 16.0% decline, while the 1 year return sits at 119.7% and the 3 year return is very large. These price moves sit against a backdrop of ongoing attention on Bel Fuse within the tech sector, as investors reassess companies that...
NYSE:BRC
NYSE:BRCCommercial Services

Will Brady’s Higher Dividend Backed by Multi‑Year Cash Flow Growth Change Brady’s (BRC) Narrative?

On February 24, 2026, Brady Corporation’s board declared a US$0.245 per-share dividend on Class A common stock, payable April 30, 2026, to shareholders of record as of April 9, 2026. This dividend decision comes alongside multi-year growth in sales, earnings, and free cash flow, underscoring Brady’s capacity to return cash to investors. We’ll now examine how Brady’s dividend declaration, against a backdrop of solid multi-year earnings and cash flow growth, influences its investment...
NYSE:VRE
NYSE:VREResidential REITs

A Look At Veris Residential (VRE) Valuation After Recent Share Price Momentum

Recent share performance and business snapshot With no single headline event driving attention to Veris Residential (VRE), the recent share performance itself is the focus, as the stock shows double digit returns over the past month and past 3 months. Veris Residential is a real estate investment trust focused on Class A multifamily properties in the Northeast. It uses a technology enabled, vertically integrated platform to manage, operate, acquire, and develop its portfolio for residents and...
NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

How Investors Are Reacting To Certara (CERT) FDA Acceptance Of Simcyp In Place Of Clinical Trials

Certara recently highlighted that its Simcyp physiologically-based pharmacokinetic modeling was accepted by the U.S. FDA in place of multiple clinical pharmacology studies to support the new drug application for asciminib (Scemblix®), an allosteric BCR::ABL1 inhibitor for Chronic Myeloid Leukemia. This decade-long modeling effort, which replaced at least ten dedicated clinical studies and informed dosing and drug-interaction decisions, underscores how biosimulation can cut development costs...